老虎證券

BUZZ-Spruce Biosciences soars after FDA's 'breakthrough therapy' tag for genetic disorder drug

Reuters
2025/10/06
BUZZ-<a href="https://laohu8.com/S/SPRB">Spruce Biosciences</a> soars after FDA's 'breakthrough therapy' tag for genetic disorder drug

** Shares of Spruce Biosciences SPRB.O rise 69% to $14.89 premarket

** Co says U.S. FDA grants "breakthrough therapy" tag for its experimental drug, tralesinidase alfa, to treat Sanfilippo Syndrome Type B

** The condition is a genetic disorder that causes progressive brain damage in children

** The breakthrough therapy tag is meant to speed up development and review of drugs to treat a serious condition or unmet medical need

** Co plans to submit application for U.S. approval in Q1 of 2026

** As of last close, stock down 72% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10